Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
08 mai 2024 16h16 HE
|
Catalyst Pharmaceuticals, Inc.
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products FIRDAPSE® Q1 2024 Net Product Revenues of...
Global Duchenne Muscular Dystrophy Drugs Business Report 2023: Market to Reach $18.1 Billion by 2030, Growing at a Staggering CAGR of 42.5%
26 janv. 2023 11h03 HE
|
Research and Markets
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Duchenne...
Global Dystrophin Market to Reach USD 30.22 Billion by 2028 - Heavy Research & Development to Boost the Market Demand – Vantage Market Research
16 févr. 2022 05h35 HE
|
Vantage Market Research
WASHINGTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The Global Dystrophin Market size is expected to reach USD 30.22 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 45.9% during the...
Duchenne Muscular Dystrophy Worldwide Outlook to 2030: Upcoming Strategies Include Gene Therapy and Cell Therapy
03 nov. 2021 05h23 HE
|
Research and Markets
Dublin, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's offering. Key...
Dystrophin Market To Reach USD 13.02 Billion By 2026 | Reports And Data
05 mars 2019 07h46 HE
|
Reports And Data
High disease prevalence across the globe coupled with ongoing research & development is expected to stimulate market growth Market Size – USD 597.3 million in 2018, Market Growth - CAGR of...